Shortages in quality-assured medicines impede efforts to reduce the prevalence of tuberculosis, malaria, and HIV/AIDS, and undermine progress in maternal and child health. Investments that build capacity of local manufacturers to produce medicines according to international quality standards and help bring low-cost, essential medicines to markets and patients faster are urgently needed.
USP collaborates with USAID, WHO, and other partners to increase the supply of priority, quality-assured, essential medicines. Our technical assistance helps companies build stronger quality-assurance systems and satisfy regulatory requirements for marketing authorization and procurement.
Areas of Technical Support & Training
- Active pharmaceutical ingredient and product development
- Technology transfer
- Process scale up
- Dossier compilation
- Good Manufacturing Practices
- WHO prequalification and Stringent Regulatory Authority (SRA) approval
- Provision of public standards